Alexia Savignoni - Concepedia

Author

Alexia Savignoni

Institut Curie ORCID

Also Known As

A SAVIGNONI, A Savignoni, A. Savignoni, Alexia Savignoni, Savignoni Alexia, Savignoni, Alexia

188

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Institut Curie Inserm Université Paris Cité Délégation Paris 5 Université Paris Sciences et Lettres

About

Alexia Savignoni is an author at Institut Curie specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	1.7K
2	Health Sciences	7	7	402
3	Public Health	4	4	152
4	Engineering	1	1	25
5	Nursing	1	1	18

Alexia Savignoni

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA) H. Ghesquières, Marion Chevrier, Mouna Laadhari, Annals of Oncology	2019	226
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer Armelle Corpet, Leanne de Koning, Joern Toedling, The EMBO Journal Tumor BiologyBreast OncologyOncologyEndocrine-related CancerMedicine	2010	180
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first Marc A. Bollet, Brigitte Sigal‐Zafrani, Valérie Mazeau, Radiotherapy and Oncology Surgical OncologyBreast OncologyMedicineCancer RecurrenceBreast Conserving Surgery	2007	140
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Youlia Kirova, Dominique Stoppa‐Lyonnet, Alexia Savignoni, European Journal of Cancer Surgical OncologyBreast Cancer RecurrenceBreast OncologyCancer RiskMedicine	2005	128
Prevalence and associated factors of sexual problems after early‐stage breast cancer treatment: results of a French exploratory survey Anne Brédart, Sylvie Dolbeault, Alexia Savignoni, Psycho-Oncology	2010	118
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma M Jehanne, Livia Lumbroso‐Le Rouic, Alexia Savignoni, Pediatric Blood & Cancer	2009	109
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients Jean‐Yves Pierga, Suzette Delaloge, Marc Espié, Breast Cancer Research and Treatment Her2 StatusBreast OncologyMedicinePharmacologyCancer Pharmacology	2010	105
Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison Hervé J. Brisse, M. Guesmi, Isabelle Aerts, Pediatric Radiology OphthalmologyMedicinePediatric OphthalmologyGlaucomaPostlaminar Invasion	2007	102
Breast-Conserving Treatment in the Elderly: Long-Term Results of Adjuvant Hypofractionated and Normofractionated Radiotherapy Youlia Kirova, François Campana, Alexia Savignoni, International Journal of Radiation OncologyBiologyPhysics Long-term ResultsRadiation MedicineBreast OncologyRadiation TherapyMedicine	2009	99
A prognostic DNA signature for T1T2 node‐negative breast cancer patients Eléonore Gravier, Gaëlle Pierron, Anne Vincent‐Salomon, Genes Chromosomes and Cancer	2010	92

Page 1